GHP Funds

SVP I

SVP I, the debut fund for the firm, closed in December 2002 and invested with four highly successful leveraged buyout funds. SVP I is diversified by sector and geography.

Learn More
SVP II

SVP II is a leveraged buyout fund of funds which closed in December 2006. SVP II represents a continuation of the successful strategy utilized by the predecessor fund, primarily investing with large, top tier LBO and growth equity firms. SVP II is diversified by sector and geography.

Learn More
SVP RE I

SVP Real Estate I, LP ("SVP RE I"), closed in February 2008, is a private real estate fund of funds. As with SVP I & II, SVP RE I received allocations with historically successful, highly sought after underlying fund managers who pursue compelling investment strategies. The fund is diversified by sector (Office, Hotel, Industrial/Warehouse, Retail and Residential) and geography (U.S., Europe, and Asia/Pacific).

Learn More
GHP COF

The GHP Credit Opportunity Fund (“GHP COF”) is a fund of alternative credit and distressed debt funds that is being raised and invested to pursue two specific investment themes: (1) the de-leveraging of European Banks, and (2) the potential for a distressed cycle in U.S. High Yield Credit. GHP COF will pursue complex liquid and illiquid credit opportunities in the U.S. and Europe.

Learn More

Monthly Archives: January 2019

Constance Finley’s Midlife Detour To Cannabis Extraction Connoisseur

Posted on by Granite Hall Partners

There is a subset of medical cannabis companies established by people who healed themselves with their own plant-based medicine, then went into business to serve others. Obviously it takes more than a compelling personal experience to get a company off the ground. It helps to live in a state such as California that has a […]


MedMen Q4 Revenue Projected to Grow 40% from Prior Quarter to $29.9 Million

Posted on by Granite Hall Partners

MedMen Releases Preliminary Second Quarter 2019 Systemwide Revenue Results LOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) (FSE: A2JM6N) announced today unaudited systemwide revenue for its fiscal 2019 second quarter ended December 29, 2018. Across the Company’s operations in California, Nevada, New York and Arizona, systemwide revenue was US$29.9 million (CA$39.7 […]


This Early MedMen Investor is Helping Institutional-Grade American Cannabis Companies Raise Capital

Posted on by Granite Hall Partners

December 23, 2018 Exclusive article by Carrie Pallardy Exclusive Interview with Chief Investment Officer of Granite Hall Partners Patrick Barry Granite Hall Partners is not a cannabis investment firm. Instead, the Chicago-based private funds company focuses on alternative investments. Over the past three years, U.S. cannabis companies have been in the firm’s toolkit for developing alternative […]